Astrazeneca PLC SEC filings AZN

Astrazeneca PLC has 1,001 filings in SEC EDGAR's recent list, going back to Jun 19, 2019. Its latest annual report, Form 20-F, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.

Astrazeneca PLC SEC filings
Form Description Filed Period
424B2 Prospectus Feb 27, 2026 —
FWP Free writing prospectus Feb 26, 2026 —
424B2 Prospectus Feb 25, 2026 —
S-8 Employee stock plan registration Feb 2, 2026 —
F-6 Filing Jan 21, 2025 —
F-3ASR Filing Mar 19, 2024 —
424B2 Prospectus Feb 23, 2024 —
FWP Free writing prospectus Feb 22, 2024 —
424B2 Prospectus Feb 21, 2024 —
S-8 Employee stock plan registration Feb 20, 2024 —
424B2 Prospectus Mar 2, 2023 —
FWP Free writing prospectus Mar 1, 2023 —
424B2 Prospectus Feb 28, 2023 —
F-6EF Registration of american depositar receipt shares Jul 19, 2021 —
424B2 Prospectus May 27, 2021 —
FWP Free writing prospectus May 26, 2021 —
FWP Free writing prospectus May 26, 2021 —
424B2 Prospectus May 24, 2021 —
F-3ASR Filing May 24, 2021 —
424B3 Prospectus Apr 13, 2021 —
F-4/A Filing Apr 9, 2021 —
F-4 Filing Feb 19, 2021 —
424B2 Prospectus Aug 5, 2020 —
FWP Free writing prospectus Aug 4, 2020 —
S-8 Employee stock plan registration Aug 3, 2020 —
FWP Free writing prospectus Aug 3, 2020 —
424B2 Prospectus Aug 3, 2020 —
F-6 Form f-6 Jan 22, 2020 —
F-3ASR Form f-3asr Nov 8, 2019 —

Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AZN (NYSE)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Cambridge
SEC filer status
Large accelerated filer
SEC CIK
901832
Former names
ZENECA GROUP PLC (until Feb 5, 1999)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.